| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/AJKD.2001.27428 |
| P698 | PubMed publication ID | 11576945 |
| P2093 | author name string | T Yamamoto | |
| S Okada | |||
| Y Kojima | |||
| A Miyauchi | |||
| M Shima | |||
| K Ozono | |||
| S Kasayama | |||
| P433 | issue | 4 Suppl 1 | |
| P921 | main subject | bone disease | Q4941552 |
| P304 | page(s) | S161-4 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
| P1476 | title | Role of advanced glycation end products in adynamic bone disease in patients with diabetic nephropathy | |
| P478 | volume | 38 |
| Q28076977 | Advanced Glycation End Products, Diabetes, and Bone Strength |
| Q27024641 | Advanced glycation end products play adverse proinflammatory activities in osteoporosis |
| Q35878806 | Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. |
| Q42814528 | Advanced glycation end products suppress lysyl oxidase and induce bone collagen degradation in a rat model of renal osteodystrophy |
| Q35804646 | Arthroplasty in veterans: analysis of cartilage, bone, serum, and synovial fluid reveals differences and similarities in osteoarthritis with and without comorbid diabetes. |
| Q90267329 | Blockade of receptors of advanced glycation end products ameliorates diabetic osteogenesis of adipose-derived stem cells through DNA methylation and Wnt signalling pathway |
| Q35825346 | Bone fragility in type 2 diabetes mellitus |
| Q37056305 | Bone metabolism and fracture risk in type 2 diabetes mellitus |
| Q36911708 | Diabetic nephropathy in the elderly. |
| Q47327491 | Dietary Advanced Glycation End Products have Sex-and Age Dependent Effects on Vertebral Bone Microstructure and Mechanical Function in Mice |
| Q58571521 | High Fat Mixed Meal Tolerance Test Leads to Suppression of Osteocalcin Decrease in Obese Insulin Resistant Subjects Compared to Healthy Adults |
| Q35795868 | Hyperglycemia increases the expression levels of sclerostin in a reactive oxygen species- and tumor necrosis factor-alpha-dependent manner |
| Q33885263 | In situ accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption |
| Q98772077 | Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus |
| Q37437155 | Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes |
| Q30241947 | Mechanisms of diabetes mellitus-induced bone fragility |
| Q26765379 | O-GlcNAcylation: a bridge between glucose and cell differentiation |
| Q53811045 | Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study. |
| Q90221054 | Pentosidine in chronic hemodialysis patients: relation with arteriovenous fistula morphology and function |
| Q79104638 | Predialysis Care in Diabetic Patients: The Missing Link? |
| Q58577346 | Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies |
Search more.